Coverage dated August 30, 2022 to September 1, 2022
CDC recommends new booster shots to fight omicron
Headline from Delaware Public Media, on the newest of 2 developments
CDC Director Rochelle Walensky has signed off on updated versions of the Moderna and Pfizer-BioNTech vaccines that target the original virus and the omicron subvariants.
Delaware Public Media's own description from its feed. We collect headlines and these descriptions, not full articles; read the original reporting below.
Developments in this update
2 dated developments, oldest first, newest marked. Each is named by one outlet's own headline; open its reports to see every outlet that covered it.
US advisers recommend updated COVID vaccine boosters
WASHINGTON (AP) -- The U.S. on Wednesday authorized its first update to COVID-19 vaccines, booster doses that target today's most common omicron strain.
The U.S. has authorized its first update to COVID-19 vaccines, booster doses that target today's most common omicron strain. Shots could begin within days.
The U.S. on Wednesday authorized its first update to covid-19 vaccines, booster doses that target today's most common omicron strain. Shots could begin within days.
The U.S. Food and Drug Administration (FDA) announced Wednesday that it has authorized updated coronavirus booster shots targeting the highly-contagious omicron variant.
Following CDC approval, new 'bivalent' shots -- which are half the original vaccine and half an Omicron-targeted version -- expected to roll out across America
WEDNESDAY, Aug. 31, 2022 (HealthDay News) -- The U.S. Food and Drug Administration on Wednesday gave the green light to updated COVID booster shots from both Pfizer and Moderna that
US health officials on Wednesday authorized updated Covid-19 vaccinations by Moderna and Pfizer-BioNTech that specifically target the latest strains of
The U.S. on Wednesday authorized its first update to COVID-19 vaccines, booster doses that target today’s most common omicron strain. Shots could begin within days.
The revamped vaccines by Moderna and BioNTech-Pfizer specifically target the currently dominant BA.4/BA.5 omicron subvariants. The jabs are part of a fall vaccination campaign that could begin within days.
The Food and Drug Administration on Wednesday authorized new COVID booster shots designed to target the omicron variant and its dominant BA.5 subvariant, but before shots can begin, there’s still another step to complete.
WASHINGTON (AP) — The U.S. on Wednesday authorized its first update to COVID-19 vaccines, booster doses that target today’s most common omicron strain. Shots could begin within days.
The Food and Drug Administration authorized re-formulated COVID-19 boosters Wednesday that target omicron variants alongside the original strain discovered in China, clearing the way for another shots-in-arms campaign to launch by next week.
